Advertisement

Research Summaries

FDA Alerts
FDA Alerts
FDA advisers back DNA-based colon cancer test
03/28/2014
...
03/28/2014
FDA Alerts
FDA Alerts
FDA panel votes against serelaxin for acute heart failure
03/28/2014
By Reuters Staff
03/28/2014
FDA Alerts
FDA Alerts
FDA approves hearing aid against tinnitus
03/28/2014
By Reuters Staff
03/28/2014
prevention
prevention
Pre-exposure HIV prophylaxis most effective in subgroup of transgender women, MSM
03/25/2014
Transgender women and men who have sex with men benefit most from pre-exposure antiretroviral drugs, whether or not they perceive their partners to be HIV negative, according to new research.
03/25/2014
FDA Alerts
FDA Alerts
FDA clears apremilast for psoriatic arthritis
03/22/2014
By Reuters Staff
03/22/2014
FDA Alerts
FDA Alerts
FDA approves Eliquis to prevent clots after hip, knee surgery
03/16/2014
By Reuters Staff
03/16/2014
Arrhythmia & EP
Arrhythmia & EP
Antibiotics Elevate Risk of Death, Cardiac Arrhythmias
03/15/2014
Researchers analyzed the association between antibiotic-use and risk of death in a new study.
03/15/2014
FDA Alerts
FDA Alerts
U.S. still weighing if genetically altered fish is safe: FDA chief
03/14/2014
...
03/14/2014
FDA Alerts
FDA Alerts
FDA-Approved: A Roundup of New Treatments on the Market
03/12/2014
From a low-dose NSAID to a migraine-treating headband, here is a round-up of the newest FDA-approved drug and treatment options.
03/12/2014
FDA Alerts
FDA Alerts
FDA probes cognitive impact of new cholesterol drugs
03/08/2014
<p>The U.S. Food and Drug Administration has called for an assessment of potential neurocognitive side effects of an experimental cholesterol drug being developed by Regeneron and Sanofi, Sanofi said...
03/08/2014